Implant Sciences Corporation, a high technology supplier of systems and sensors for homeland security and defense markets, announced today that the QS-B220 explosives and drugs trace detector has been issued a SAFETY Act Designation (as defined in Section 25.2 of the Regulations) from the Department of Homeland Security. The QS-H150 handheld explosive trace detector also holds a SAFETY Act Designation.
The Support Anti-terrorism by Fostering Effective Technologies Act of 2002 (SAFETY Act) was enacted as part of the Homeland Security Act of 2002. The SAFETY Act is intended to facilitate the development and deployment of effective anti-terrorism technologies by providing product liability protection. The Act creates liability limitations for claims arising out of, relating to, or resulting from an "Act of Terrorism" where Qualified Anti-Terrorism Technologies have been deployed.
Glenn D. Bolduc, Implant Sciences' President and CEO, stated, "SAFETY Act Designation is an important achievement, especially for our non-government customers. Coupled with our insurance coverage, the liability limitations built into the Act provide protection against lawsuits arising from the use of Implant Sciences' ETD equipment in defending against terrorism. We have had key accounts cite SAFETY Act Designation as one of their requirements for purchase and we anticipate that our receiving it will help us continue to build sales momentum for the QS-B220."